- Home
- IHRT vs ACIU Comparison
IHRT vs ACIU Comparison
Compare IHRT & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHRT
- ACIU
- Stock Information
- Founded
- IHRT 1974
- ACIU 2003
- Country
- IHRT United States
- ACIU Switzerland
- Employees
- IHRT N/A
- ACIU N/A
- Industry
- IHRT Broadcasting
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- IHRT Consumer Discretionary
- ACIU Health Care
- Exchange
- IHRT Nasdaq
- ACIU Nasdaq
- Market Cap
- IHRT 193.4M
- ACIU 189.1M
- IPO Year
- IHRT 2019
- ACIU 2016
- Fundamental
- Price
- IHRT $2.03
- ACIU $2.04
- Analyst Decision
- IHRT Buy
- ACIU Strong Buy
- Analyst Count
- IHRT 3
- ACIU 1
- Target Price
- IHRT $2.92
- ACIU $12.00
- AVG Volume (30 Days)
- IHRT 780.4K
- ACIU 123.5K
- Earning Date
- IHRT 08-07-2025
- ACIU 08-05-2025
- Dividend Yield
- IHRT N/A
- ACIU N/A
- EPS Growth
- IHRT N/A
- ACIU N/A
- EPS
- IHRT N/A
- ACIU N/A
- Revenue
- IHRT $3,862,595,000.00
- ACIU $32,014,254.00
- Revenue This Year
- IHRT N/A
- ACIU N/A
- Revenue Next Year
- IHRT $5.89
- ACIU $533.21
- P/E Ratio
- IHRT N/A
- ACIU N/A
- Revenue Growth
- IHRT 3.31
- ACIU 91.20
- 52 Week Low
- IHRT $0.95
- ACIU $1.43
- 52 Week High
- IHRT $2.84
- ACIU $4.26
- Technical
- Relative Strength Index (RSI)
- IHRT 73.86
- ACIU 54.21
- Support Level
- IHRT $1.64
- ACIU $1.94
- Resistance Level
- IHRT $2.13
- ACIU $2.15
- Average True Range (ATR)
- IHRT 0.13
- ACIU 0.16
- MACD
- IHRT 0.02
- ACIU -0.00
- Stochastic Oscillator
- IHRT 87.76
- ACIU 72.22
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.